CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
immunogenicity of APG777 in adult participants with mild-to-moderate asthma.The duration of the study will be approximately 52 weeks (364 da...
Phase 1
Pittsburgh, Pennsylvania, United States and 9 other locations
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....
Phase 2
Pittsburgh, Pennsylvania, United States and 147 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Pittsburgh, Pennsylvania, United States and 73 other locations
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....
Phase 3
Scottdale, Pennsylvania, United States and 134 other locations
efficacy of lunsekimig in adult participants with moderate-to-severe asthma who have previously completed the parent study. After completion...
Phase 2
Pittsburgh, Pennsylvania, United States and 19 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 382 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Pittsburgh, Pennsylvania, United States and 397 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 361 other locations
safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 161 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Pittsburgh, Pennsylvania, United States and 359 other locations
Clinical trials
Research sites
Resources
Legal